CRP and colorectal carcinoma: The focus is on exploring the relationship between traditional inflammatory markers, such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and newly introduced indices like C-reactive protein (CRP)–albumin–lymphocyte (CALLY), and their association with CRC progression and lung metastasis.